Explore Our Biomarker Menu

Biological or Clinical Significance:

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. The EGFR is essential for ductal development of the mammary glands, and agonists of the EGFR such as amphiregulin, TGF-α, and heregulin induce both ductal and lobuloalveolar development even in the absence of estrogen and progesterone.

Epidermal Growth Factor Receptor (EGFR) is a gene involved in making cells grow and multiply. EGFR activating mutations are believed to cause the cells to multiply excessively.
Epidermal growth factor (EGF) pathway inhibition is now established as an option for the first-, second- and third-line treatments of non–small-cell lung cancer (NSCLC). Soluble epidermal growth factor receptor (sEGFR/sErbB1) is a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

References:

Analyte:

sEGFR

Matrix:

Human Serum

Status:

Experienced Running

Sensitivity-LLOQ:

610 pg/mL

Sensitivity-ULOQ:

2,500,000 pg/mL

platform

Luminex, MSD-ECL

Required Sample Volume

50 µL/well

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.